LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

CERM: CONSIDERATIONS FOR DEVELOPING A GREENER CHROMATOGRAPHIC METHOD

Posters | 2023 | WatersInstrumentation
HPLC, LC/TOF, LC/HRMS, LC/MS
Industries
Manufacturer
Waters

Summary

Significance of the Topic


Reducing the environmental footprint of high-performance liquid chromatography is critical in modern analytical laboratories. By minimizing use of toxic or energy-intensive solvents and lowering solvent consumption through column miniaturization, greener methods help meet regulatory expectations and sustainability goals without compromising analytical performance.

Objectives and Study Overview


This work explores two strategies to develop more eco-friendly reversed-phase chromatography methods:
  • Study 1: Reduction of acetonitrile consumption by scaling column dimensions while maintaining separation efficiency using a model NSAID (naproxen sodium).
  • Study 2: Replacement of acetonitrile with less toxic solvents (methanol or isopropyl alcohol) in intact monoclonal antibody (mAb) mass analysis.

Methodology


Study 1 employed three column formats (4.6×150 mm, 3.0×75 mm, 2.1×50 mm) packed with C8 particles of decreasing size to preserve the length-to-particle diameter ratio. The mobile phase was acetonitrile : water : acetic acid (45 : 54 : 1 v/v/v) and flow rates were scaled to achieve comparable analysis times.
Study 2 used reversed-phase LC – MS to analyze a NIST reference mAb with three mobile phases (95% acetonitrile, methanol or isopropyl alcohol, each with 0.1% formic acid), assessing raw and deconvoluted mass spectra quality.

Used Instrumentation


  • Alliance HPLC with UV/Vis detector
  • ACQUITY Arc and H-Class UPLC systems with PDA detectors
  • BioAccord UPLC I-Class PLUS with ACQUITY RDa mass detector
  • Columns: XBridge BEH C8 (5 µm), XBridge BEH C8 XP (2.5 µm), CORTECS UPLC C8 (1.6 µm), BioResolve RP mAb Polyphenyl (2.7 µm)

Main Results and Discussion


Column miniaturization led to a four-fold reduction in acetonitrile usage by switching from 4.6×150 mm to 3.0×75 mm format, and up to thirteen-fold reduction with a 2.1×50 mm column, while preserving chromatographic performance.
In mAb analyses, isopropyl alcohol produced comparable or slightly improved raw mass spectra compared with acetonitrile, showing better desolvation and charge-state envelopes. Methanol performed acceptably but gave slightly higher valley intensities. System pressure increased with IPA but remained within safe operational limits.

Benefits and Practical Applications


  • Substantial reduction in hazardous solvent consumption lowers cost and waste disposal burden.
  • Maintained or improved analytical quality in small-molecule and biotherapeutic separations.
  • Compatibility with existing high-pressure systems enables rapid adoption.

Future Trends and Applications


Advances may include wider adoption of sub-2 µm and superficially porous particles in ultra-high-pressure systems, exploration of alternative green solvents and solvent mixtures, and use of AI-driven method optimization to further reduce solvent usage and energy demands. Continuous flow and microfluidic approaches could drive next-generation sustainable chromatography.

Conclusion


Method development strategies that combine column dimension scaling and solvent selection deliver greener reversed-phase HPLC and LC – MS methods. By reducing acetonitrile consumption and validating isopropyl alcohol for mAb analysis, laboratories can achieve robust separations while meeting sustainability targets.

References


  • Collaboration to Deliver a Solvent Selection Guide for the Pharmaceutical Industry, ACS Green Chemistry Institute Pharmaceutical Roundtable.
  • Shion H et al. Enabling Routine and Reproducible Intact Analysis When Data Integrity Matters. Waters Application Note 720006472EN, 2019.
  • FDA Q3C Guidance for Industry, Tables and List Guidance, 2014.
  • Li J. Selection of Solvents and Mobile Phases for HPLC to Optimize Sensitivity of UV Detection, Analysis and Purification 2(1):72–75, 1987.
  • Li J. Signal-to-Noise Optimization in HPLC UV Detection, LC-GC 10(11):856–864, 1992.
  • Snyder L. Practical HPLC Method Development, 2nd ed., pp.59–79, 722–726, 1997.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Greener, Lower Cost Organic Mobile Phase Solvents for the LC-MS Analysis of Intact Biotherapeutic Proteins
Application Note Greener, Lower Cost Organic Mobile Phase Solvents for the LC-MS Analysis of Intact Biotherapeutic Proteins Henry Shion, Ying Qing Yu Waters Corporation Abstract This application note presents on the recent trend replacing acetonitrile (Class II Toxicity) with greener…
Key words
intact, intactsubunit, subunitipa, ipagreener, greeneranalysis, analysismass, massacetonitrile, acetonitrilebioaccord, bioaccordnistmab, nistmabgradient, gradientacentonitrile, acentonitriledesolvantion, desolvantionspectromety, spectrometyacquity, acquityisopropanol
Guide to Size-Exclusion Chromatography (SEC) of mAb Aggregates, Monomers, and Fragments
Guide to Size-Exclusion Chromatography (SEC) of mAb Aggregates, Monomers, and Fragments 1 Table of Contents I. Introduction II. Importance of Developing a Robust LC-based SEC Method a. Choosing the Appropriate Protein BEH SEC Column b. Method Development III. Considerations When…
Key words
column, columnbeh, behsec, secuplc, uplcacquity, acquityprotein, proteinexpected, expectedrecommendation, recommendationdimension, dimensionprime, primehmw, hmwcolumns, columnsstandard, standardmab, mabionic
APPLICATION NOTEBOOK - IMPURITIES - Developing Safe and Effective Drugs
[ APPLICATION NOTEBOOK ] IMPURITIES Developing Safe and Effective Drugs INT RODUCTION NAVIGATION T he pharmaceutical industry is integral in maintaining public health by providing therapeutic and preventative medicines. T he cornerstones of bringing new medicines to market are quality,…
Key words
home, homeuplc, uplcimpurities, impuritiesziprasidone, ziprasidoneusp, uspacquity, acquityimpurity, impuritymethod, methodtioconazole, tioconazoleminutes, minutessimvastatin, simvastatinhplc, hplcusing, usingrelated, relatedanalysis
Waters ACQUITY Premier Protein SEC 250 Å, 1.7 μm Columns - CARE AND USE MANUAL
[ CARE AND USE MANUAL ] ACQUITY Premier Protein SEC 250 Å, 1.7 µm Columns CONTENTS I. INTRODUCTION Thank you for choosing a Waters™ SEC Column. The ACQUITY™ I. INTRODUCTION II. SEC ANALYSIS OF PROTEIN AGGREGATES, MONOMERS, AND FRAGMENTS…
Key words
column, columnmab, mabcare, carevariant, variantsec, secuse, usemanual, manualpremier, premierprotein, proteinionhance, ionhancemonomer, monomersize, sizehmws, hmwsrecommended, recommendedwaters
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike